Followers | 1350 |
Posts | 34966 |
Boards Moderated | 1 |
Alias Born | 09/22/2011 |
Wednesday, June 28, 2017 5:09:56 PM
Shanghai based Vital Strategic Research Institute (VSRI) is a medical research firm with a long history of expertise in design, clinical trials and global research. VSRI has collaborated with pharmaceutical giants such as Pfizer and Bristol-Myers Squibb. The Company sees VSRI as a major opportunity in the world's largest country and second largest consumer market. VSRIs profits showed a dramatic increase in 2016 and the Company fully expects this growth to continue. The Company will release VSRIs June 30, 2017 financial statements in the first half of July. VSRI has websites in both English and Chinese.
http://www.vitalstrategic.com/collaborators.html
http://www.vitalstrategic.com.cn/Home/cooperatingagency
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM